128 related articles for article (PubMed ID: 16442799)
1. 2D Autocorrelation modeling of the negative inotropic activity of calcium entry blockers using Bayesian-regularized genetic neural networks.
Caballero J; Garriga M; Fernández M
Bioorg Med Chem; 2006 May; 14(10):3330-40. PubMed ID: 16442799
[TBL] [Abstract][Full Text] [Related]
2. Ensembles of Bayesian-regularized genetic neural networks for modeling of acetylcholinesterase inhibition by huprines.
Fernández M; Caballero J
Chem Biol Drug Des; 2006 Oct; 68(4):201-12. PubMed ID: 17105484
[TBL] [Abstract][Full Text] [Related]
3. Bayesian-regularized genetic neural networks applied to the modeling of non-peptide antagonists for the human luteinizing hormone-releasing hormone receptor.
Fernández M; Caballero J
J Mol Graph Model; 2006 Dec; 25(4):410-22. PubMed ID: 16574448
[TBL] [Abstract][Full Text] [Related]
4. Proteochemometric modeling of the inhibition complexes of matrix metalloproteinases with N-hydroxy-2-[(phenylsulfonyl)amino]acetamide derivatives using topological autocorrelation interaction matrix and model ensemble averaging.
Fernández M; Fernández L; Caballero J; Abreu JI; Reyes G
Chem Biol Drug Des; 2008 Jul; 72(1):65-78. PubMed ID: 18554254
[TBL] [Abstract][Full Text] [Related]
5. QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.
Fernández M; Caballero J
Bioorg Med Chem; 2007 Sep; 15(18):6298-310. PubMed ID: 17590339
[TBL] [Abstract][Full Text] [Related]
6. Amino Acid Sequence Autocorrelation vectors and ensembles of Bayesian-Regularized Genetic Neural Networks for prediction of conformational stability of human lysozyme mutants.
Caballero J; Fernández L; Abreu JI; Fernández M
J Chem Inf Model; 2006; 46(3):1255-68. PubMed ID: 16711745
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements of pyrido[2,3-d]pyrimidin-7-one as CDK4/D inhibitors: 2D autocorrelation, CoMFA and CoMSIA analyses.
Caballero J; Fernández M; González-Nilo FD
Bioorg Med Chem; 2008 Jun; 16(11):6103-15. PubMed ID: 18468903
[TBL] [Abstract][Full Text] [Related]
8. 2D autocorrelation modelling of the inhibitory activity of cytokinin-derived cyclin-dependent kinase inhibitors.
González MP; Caballero J; Helguera AM; Garriga M; González G; Fernández M
Bull Math Biol; 2006 May; 68(4):735-51. PubMed ID: 16802081
[TBL] [Abstract][Full Text] [Related]
9. Protein radial distribution function (P-RDF) and Bayesian-Regularized Genetic Neural Networks for modeling protein conformational stability: chymotrypsin inhibitor 2 mutants.
Fernández M; Caballero J; Fernández L; Abreu JI; Garriga M
J Mol Graph Model; 2007 Nov; 26(4):748-59. PubMed ID: 17569565
[TBL] [Abstract][Full Text] [Related]
10. Genetic algorithm applied to the selection of factors in principal component-artificial neural networks: application to QSAR study of calcium channel antagonist activity of 1,4-dihydropyridines (nifedipine analogous).
Hemmateenejad B; Akhond M; Miri R; Shamsipur M
J Chem Inf Comput Sci; 2003; 43(4):1328-34. PubMed ID: 12870926
[TBL] [Abstract][Full Text] [Related]
11. Modeling of farnesyltransferase inhibition by some thiol and non-thiol peptidomimetic inhibitors using genetic neural networks and RDF approaches.
González MP; Caballero J; Tundidor-Camba A; Helguera AM; Fernández M
Bioorg Med Chem; 2006 Jan; 14(1):200-13. PubMed ID: 16185882
[TBL] [Abstract][Full Text] [Related]
12. Linear and nonlinear QSAR study of N-hydroxy-2-[(phenylsulfonyl)amino]acetamide derivatives as matrix metalloproteinase inhibitors.
Fernández M; Caballero J; Tundidor-Camba A
Bioorg Med Chem; 2006 Jun; 14(12):4137-50. PubMed ID: 16504515
[TBL] [Abstract][Full Text] [Related]
13. Modeling of cyclin-dependent kinase inhibition by 1H-pyrazolo[3,4-d]pyrimidine derivatives using artificial neural network ensembles.
Fernández M; Tundidor-Camba A; Caballero J
J Chem Inf Model; 2005; 45(6):1884-95. PubMed ID: 16309296
[TBL] [Abstract][Full Text] [Related]
14. Application of ab initio theory to QSAR study of 1,4-dihydropyridine-based calcium channel blockers using GA-MLR and PC-GA-ANN procedures.
Hemmateenejad B; Safarpour MA; Miri R; Taghavi F
J Comput Chem; 2004 Sep; 25(12):1495-503. PubMed ID: 15224393
[TBL] [Abstract][Full Text] [Related]
15. Robust QSAR models using Bayesian regularized neural networks.
Burden FR; Winkler DA
J Med Chem; 1999 Aug; 42(16):3183-7. PubMed ID: 10447964
[TBL] [Abstract][Full Text] [Related]
16. Broad-based quantitative structure-activity relationship modeling of potency and selectivity of farnesyltransferase inhibitors using a Bayesian regularized neural network.
Polley MJ; Winkler DA; Burden FR
J Med Chem; 2004 Dec; 47(25):6230-8. PubMed ID: 15566293
[TBL] [Abstract][Full Text] [Related]
17. Linear and nonlinear modeling of antifungal activity of some heterocyclic ring derivatives using multiple linear regression and Bayesian-regularized neural networks.
Caballero J; Fernández M
J Mol Model; 2006 Jan; 12(2):168-81. PubMed ID: 16205958
[TBL] [Abstract][Full Text] [Related]
18. Predictive Bayesian neural network models of MHC class II peptide binding.
Burden FR; Winkler DA
J Mol Graph Model; 2005 Jun; 23(6):481-9. PubMed ID: 15878832
[TBL] [Abstract][Full Text] [Related]
19. Modelling blood-brain barrier partitioning using Bayesian neural nets.
Winkler DA; Burden FR
J Mol Graph Model; 2004 Jul; 22(6):499-505. PubMed ID: 15182809
[TBL] [Abstract][Full Text] [Related]
20. Prediction of air-to-blood partition coefficients of volatile organic compounds using genetic algorithm and artificial neural network.
Konoz E; Golmohammadi H
Anal Chim Acta; 2008 Jul; 619(2):157-64. PubMed ID: 18558108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
